# Rydex Biotechnology C (RYCFX)

> Source: Nexqual · https://nexqual.com/RYCFX · data as of 2026-10-24 00:03 UTC · cite as "Nexqual, Rydex Biotechnology C (RYCFX), nexqual.com/RYCFX" · informational, not investment advice.

**Price:** USD 53.99 (-0.83% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 54.44 · day 53.99–53.99 · 52w 41.36–56.5 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y +35.8% vs S&P 500 +13.4%; 5Y +39.0% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +35.8% | +39.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +36.0% | +6.8% |
| Volatility (annualized) | 22.0% | 25.1% |
| Max drawdown | -8.5% (Jan 2026→Mar 2026) | -30.6% (Dec 2024→Mar 2025) |

## Peers
RYHCX (Rydex Health Care - C Class) USD 108.82 +0.00% · RYECX (Rydex Energy - C Class) USD 276.09 +0.00% · RYOAX (Rydex Series Fds, Biotechnology) USD 73 +0.00% · RYCHX (Rydex Technology Fund - C Class) USD 236.37 +0.00% · RYSCX (Rydex Electronics Fund - C Clas) USD 614.26 -0.00%

## More
Full page: https://nexqual.com/RYCFX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt